AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Embryonic development of multilineage hematopoiesis requires the precisely regulated expression of lineage-specific transcription factors, including AML-1 (encoded by Runx1; also known as CBFA-2 or PEBP-2alphaB). In vitro studies and findings in human diseases, including leukemias, myelodysplastic syndromes and familial platelet disorder with predisposition to acute myeloid leukemia (AML), suggest that AML-1 has a pivotal role in adult hematopoiesis. However, this role has not been fully uncovered in vivo because of the embryonic lethality of Runx1 knockout in mice. Here we assess the requirement of AML-1/Runx1 in adult hematopoiesis using an inducible gene-targeting method. In the absence of AML-1, hematopoietic progenitors were fully maintained with normal myeloid cell development. However, AML-1-deficient bone marrow showed inhibition of megakaryocytic maturation, increased hematopoietic progenitor cells and defective T- and B-lymphocyte development. AML-1 is thus required for maturation of megakaryocytes and differentiation of T and B cells, but not for maintenance of hematopoietic stem cells (HSCs) in adult hematopoiesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The transcription factor RUNX-1 plays a key role in megakaryocyte differentiation and is mutated in cases of myelodysplastic syndrome and leukemia.”
From Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. (2009) · cites this paper as [18]
In the citing paper
“Conditional knockout studies of mice demonstrate a specific role for RUNX-1 in megakaryocyte differentiation during adult stages of hematopoiesis”
From Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. (2009) · cites this paper as [18]
In the citing paper
“RUNX-1-deficient megakaryocytes have hypolobulated nuclei, underdeveloped cytoplasm, low DNA ploidy, and enhanced replating activity in semisolid medium culture assays.”
From Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. (2009) · cites this paper as [18]
Citations
Cites
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
Kondo, M., Weissman, I. L., & Akashi, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80453-5 · Cited by 2,253 · cited 1×
“1b ), the cells defined by Lin −/lo IL-7Rα + Sca-1 lo c-Kit lo , previously reported to include common lymphocyte progenitors (CLPs”
BackgroundLong-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
Osawa, M., Hanada, K.-I., Hamada, H., & Nakauchi, H. (1996) · Science · doi:10.1126/science.273.5272.242 · Cited by 2,140
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
Inducible Gene Targeting in Mice
Kühn, R., Schwenk, F., Aguet, M., & Rajewsky, K. (1995) · Science · doi:10.1126/science.7660125 · Cited by 1,641 · cited 1×
“Here we assess the requirement of AML-1/ Runx1 in adult hematopoiesis using an inducible gene-targeting metho”
MethodWang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A. H., & Speck, N. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3444 · Cited by 1,178
Song, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., et al. (1999) · Nature Genetics · doi:10.1038/13793 · Cited by 1,100
Transcription Factors, Normal Myeloid Development, and Leukemia
Tenen, D. G., Hromas, R., Licht, J. D., & Zhang, D.-E. (1997) · Blood · doi:10.1182/blood.v90.2.489 · Cited by 735 · cited 1×
“In vitro studies and findings in human diseases, including leukemia”
BackgroundTaniuchi, I., Osato, M., Egawa, T., Sunshine, M. J., Bae, S.-C., Komori, T., Ito, Y., & Littman, D. R. (2002) · Cell · doi:10.1016/s0092-8674(02)01111-x · Cited by 730
Shivdasani, R. A., Fujiwara, Y., McDevitt, M. A., & Orkin, S. H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3965 · Cited by 674
North, T. E., de Bruijn, M. F. T. R., Stacy, T., Talebian, L., Lind, E., Robin, C., Binder, M., Dzierzak, E., & Speck, N. A. (2002) · Immunity · doi:10.1016/s1074-7613(02)00296-0 · Cited by 583
Cited by
Hematopoiesis: An Evolving Paradigm for Stem Cell Biology
Orkin, S. H., & Zon, L. I. (2008) · Cell · doi:10.1016/j.cell.2008.01.025 · Cited by 2,570
“Similarly, inactivation of Runx1 in adult HSCs does not ablate HSC properties but instead perturbs differentiation of specific lineages (megakaryocytes, lymphocytes) (Ichikawa et al., 2004).”
BackgroundRunx1 is required for the endothelial to haematopoietic cell transition but not thereafter
Chen, M. J., Yokomizo, T., Zeigler, B. M., Dzierzak, E., & Speck, N. A. (2009) · Nature · doi:10.1038/nature07619 · Cited by 1,013
“In summary, the most essential function of Runx1 is during the transition from VEC + cells to Vav + HSCs, although it continues to provide important activity in maintaining normal HSC function and for the terminal differentiation of some lineages 25, 26 (Supplementary Figure 1).”
Transcription factors in myeloid development: balancing differentiation with transformation
Rosenbauer, F., & Tenen, D. G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2024 · Cited by 606
Mechanisms of Stem Cell Self-Renewal
Shenghui, H., Nakada, D., & Morrison, S. J. (2009) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.042308.113248 · Cited by 603
“Fetal and neonatal HSC maintenance depends on AML1 and Sox17, but these transcription factors are not required for the maintenance of adult HSCs (Ichikawa et al. 2004, Kim et al. 2007, Okuda et al. 1996).”
BackgroundAcute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1.
Rosenbauer, F., Wagner, K., Kutok, J. L., Iwasaki, H., Le Beau, M. M., Okuno, Y., Akashi, K., Fiering, S., & Tenen, D. G. (2004) · Nature Genetics · doi:10.1038/ng1361 · Cited by 506
“Like mice deficient in other transcription factors implicated in human AM”
BackgroundLoss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype
Growney, J. D., Shigematsu, H., Li, Z., Lee, B. H., Adelsperger, J., Rowan, R., Curley, D. P., Kutok, J. L., Akashi, K., Williams, I. R., et al. (2005) · Blood · doi:10.1182/blood-2004-08-3280 · Cited by 462
The runx genes: gain or loss of function in cancer
Blyth, K., Cameron, E. R., & Neil, J. C. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1607 · Cited by 455
“, a recent study involving targeted deletion in established haematopoietic stem cells led to an expansion of these cells in bone marrow, indicating that alterations to the self-renewal capacity of progenitor cells might be a priming event for leukaemic transformation in cells lacking RUNX1 functio”
BackgroundKim, I., Saunders, T. L., & Morrison, S. J. (2007) · Cell · doi:10.1016/j.cell.2007.06.011 · Cited by 421
The RUNX family: developmental regulators in cancer
Ito, Y., Bae, S.-C., & Chuang, L. S. H. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3877 · Cited by 399
Oncogenic potential of the RUNX gene family: ‘Overview’
Ito, Y. (2004) · Oncogene · doi:10.1038/sj.onc.1207755 · Cited by 316
“The phenotype of recently available mice with conditionally disrupted Runx1 may provide important clues on this issue (Ichikawa et al., 2004).”
BackgroundMolecular biomarkers in acute myeloid leukemia
Prada-Arismendy, J., Arroyave, J. C., & Röthlisberger, S. (2017) · Blood Reviews · doi:10.1016/j.blre.2016.08.005 · Cited by 304
PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis
Dakic, A., Metcalf, D., Di Rago, L., Mifsud, S., Wu, L., & Nutt, S. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050075 · Cited by 297
“In support of these ontogenic differences, several transcription factors that are known to be essential for embryonic hematopoiesis, including acute myeloid leukemia (AML)-1 (7) and SCL (8), display very different phenotypes when deleted in adult mice.”
BackgroundTel/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survival
Hock, H., Meade, E., Medeiros, S., Schindler, J. W., Valk, P. J. M., Fujiwara, Y., & Orkin, S. H. (2004) · Genes & Development · doi:10.1101/gad.1239604 · Cited by 296
“2003), Aml1/runx1 (Ichikawa et al. 2004), Notch1 (Radtke et al.”
BackgroundHaploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis
Rodrigues, N. P. (2005) · Blood · doi:10.1182/blood-2004-08-2989 · Cited by 297
Limiting Factors in Murine Hematopoietic Stem Cell Assays
Purton, L. E., & Scadden, D. T. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.016 · Cited by 293
Tijssen, M. R., Cvejic, A., Joshi, A., Hannah, R. L., Ferreira, R., Forrai, A., Bellissimo, D. C., Oram, S. H., Smethurst, P. A., Wilson, N. K., et al. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.04.008 · Cited by 289
“…other TFs investigated in this study, GATA2, RUNX1, FLI1, and SCL, have also been previously shown to play important roles in MK differentiation (Growney et al., 2005; Hart et al., 2000; Huang et al., 2009b; Ichikawa et al., 2004; Mik-kola et al., 2003; Song et al., 1999; Spyropoulos et al., 2000).”
Gaidzik, V. I., Teleanu, V, Papaemmanuil, E., Weber, D., Paschka, P., Hahn, J., Wallrabenstein, T., Kolbinger, B., Köhne, C. H., Horst, H. A., et al. (2016) · Leukemia · doi:10.1038/leu.2016.126 · Cited by 279
Mll Has a Critical Role in Fetal and Adult Hematopoietic Stem Cell Self-Renewal
McMahon, K. A., Hiew, S. Y.-L., Hadjur, S., Veiga-Fernandes, H., Menzel, U., Price, A. J., Kioussis, D., Williams, O., & Brady, H. J. M. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.07.002 · Cited by 273
“A similar scenario has been reported for other genes known to be important for fetal hematopoiesis when deleted in adults (Ichikawa et al., 2004; Mikkola et al., 2003).”
BackgroundLoughran, S. J., Kruse, E. A., Hacking, D. F., de Graaf, C. A., Hyland, C. D., Willson, T. A., Henley, K. J., Ellis, S., Voss, A. K., Metcalf, D., et al. (2008) · Nature Immunology · doi:10.1038/ni.1617 · Cited by 269
“Notably, Runx1 seems to be dispensable in HSCs once hematopoiesis has been establishe”
BackgroundPoint mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia
Osato, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207779 · Cited by 268
“Conditional Runx1 knockout mice showed apparent defects in hematopoiesis (Ichikawa et al., 2004), whereas hematopoiesis in conditional heterozygous RUNX1-ETO knockin mice was nearly normal (Higuchi et al., 2002), suggesting that Runx1 / induces more severe effects than the RUNX1-ETO chimeric gene…”
BackgroundNew Insights Into the Differentiation of Megakaryocytes From Hematopoietic Progenitors
Noetzli, L. J., French, S. L., & Machlus, K. R. (2019) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.312129 · Cited by 263
“differentiation, are also essential for fetal HSC determination, but are dispensable for adult HSC maintenance.(71,72) Likewise, GATA2 is required for HSC maintenance as well as further downstream during early megakaryopoiesis.”
BackgroundRole of transforming growth factor-β in hematologic malignancies
Dong, M., & Blobe, G. C. (2006) · Blood · doi:10.1182/blood-2005-10-4169 · Cited by 260
MOLECULAR GENETICS OF T CELL DEVELOPMENT
Rothenberg, E. V., & Taghon, T. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115737 · Cited by 261
PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis.
Huang, G., Zhang, P., Hirai, H., Elf, S., Yan, X., Chen, Z., Koschmieder, S., Okuno, Y., Dayaram, T., Growney, J. D., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.7 · Cited by 259
“However, loss of AML1 in adult mice led to thrombocytopenia due to immaturity of megakaryocytes in the bone marrow, an increase in myeloid progenitors, splenomegaly with expansion of the myeloid compartment, a small thymus populated by immature double negative thymocytes, and defective B-cell developmen”
BackgroundSelf-citationBowie, M. B., Kent, D. G., Dykstra, B., McKnight, K. D., McCaffrey, L., Hoodless, P. A., & Eaves, C. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700460104 · Cited by 256
A requirement for Notch1 distinguishes 2 phases of definitive hematopoiesis during development
Hadland, B. K., Huppert, S. S., Kanungo, J., Xue, Y., Jiang, R., Gridley, T., Conlon, R. A., Cheng, A. M., Kopan, R., & Longmore, G. D. (2004) · Blood · doi:10.1182/blood-2004-03-1224 · Cited by 240
Azcoitia, V., Aracil, M., Martínez-A, C., & Torres, M. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2005.01.004 · Cited by 240
Cai, X., Gao, L., Teng, L., Ge, J., Oo, Z. M., Kumar, A. R., Gilliland, D. G., Mason, P. J., Tan, K., & Speck, N. A. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.06.002 · Cited by 235
“In mice, loss-of-function (LOF) Runx1 mutations cause defects in lymphocyte and megakaryocytic development, and alterations in hematopoietic stem and progenitor cells (HSPCs) that include an increase in the number of committed erythroid/myeloid progenitors and expansion of the lineage-negative (L) Sca1 Kit (LSK) popul…”
The cancer stem cell hypothesis: in search of definitions, markers, and relevance
Shipitsin, M., & Polyak, K. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.14 · Cited by 231
“Specifically, the percentage of CD44þCD24 =lo cells ranged from 0–40% in the normal breast and from 0% to 80% in tumor tissues [30].”
BackgroundCore-binding factors in hematopoiesis and immune function
de Bruijn, M. F., & Speck, N. A. (2004) · Oncogene · doi:10.1038/sj.onc.1207763 · Cited by 231
“…a severe impairment of platelet formation and megakaryocyte differentiation, evidenced by the replacement of normal megakaryocytes with ‘micromegakaryocytes’ in BM, that was accompanied by an increase in the number of in vitro megakaryocyte clonogenic progenitors (CFU-Meg) (Ichikawa et al., 2004).”
BackgroundResultInfluentialMOZ is essential for maintenance of hematopoietic stem cells
Katsumoto, T., Aikawa, Y., Iwama, A., Ueda, S., Ichikawa, H., Ochiya, T., & Kitabayashi, I. (2006) · Genes & Development · doi:10.1101/gad.1393106 · Cited by 222
“AML1 is essential for generation of hematopoietic stem cells (Okuda et al. 1996; Wang et al. 1996a), and is important for differentiation of megakaryocytes and lymphocytes (Ichikawa et al. 2004; Growney et al. 2005).”
BackgroundRUNX proteins in transcription factor networks that regulate T-cell lineage choice
Collins, A., Littman, D. R., & Taniuchi, I. (2009) · Nature Reviews Immunology · doi:10.1038/nri2489 · Cited by 219
Yu, M., Mazor, T., Huang, H., Huang, H.-T., Kathrein, K. L., Woo, A. J., Chouinard, C. R., Labadorf, A., Akie, T. E., Moran, T. B., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.11.032 · Cited by 215
“, 2008), whereas Runx1 loss predominantly impairs the DN2 (CD44CD25) to DN3 transition (Ichikawa et al., 2004).”
InfluentialRUNX transcription factors: orchestrators of development
Mevel, R., Draper, J. E., Lie-a-Ling, M., Kouskoff, V., & Lacaud, G. (2019) · Development · doi:10.1242/dev.148296 · Cited by 211
Origins of leukaemia in children with Down syndrome
Hitzler, J. K., & Zipursky, A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1525 · Cited by 211
“RUNX1 is essential for the terminal differentiation of megakaryocytic progenitor”
BackgroundRunx transcription factors in the development and function of the definitive hematopoietic system
de Bruijn, M., & Dzierzak, E. (2017) · Blood · doi:10.1182/blood-2016-12-689109 · Cited by 209
Congenital disorders associated with platelet dysfunctions
Nurden, P., & Nurden, A. T. (2008) · Thrombosis and Haemostasis · doi:10.1160/th07-09-0568 · Cited by 206
(2008) · Advances in Cancer Research · doi:10.1016/s0065-230x(07)99002-8 · Cited by 203
Göthert, J. R., Gustin, S. E., Hall, M. A., Green, A. R., Göttgens, B., Izon, D. J., & Begley, C. G. (2005) · Blood · doi:10.1182/blood-2004-08-3037 · Cited by 203
An Ancient Role for a Prokineticin Domain in Invertebrate Hematopoiesis
Söderhäll, I., Kim, Y.-A., Jiravanichpaisal, P., Lee, S.-Y., & Söderhäll, K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6153 · Cited by 196
“In addition to a role in embryonic hematopoiesis and differentiation of megakaryocytes and lymphocytes during adult hematopoiesis (32), recent reports also support a role for Runx genes in angiogenetic growth, and vascular endothelial cells express Runx genes activated by angiogenic factors (33).”
BackgroundTranscription factor RUNX1 promotes survival of acute myeloid leukemia cells
Goyama, S., Schibler, J., Cunningham, L., Zhang, Y., Rao, Y., Nishimoto, N., Nakagawa, M., Olsson, A., Wunderlich, M., Link, K. A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68557 · Cited by 196
“Another Runx1 mutant mouse strain with loxP-flanked exon 5 (52)”
Self-citationInterplay between interferon and other cytokine systems in bone metabolism
Takayanagi, H., Sato, K., Takaoka, A., & Taniguchi, T. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00337.x · Cited by 191
“Runx family transcription factors play an important role in various biological systems such as hematopoiesis, bone metabolism, and oncogenesis (86, 87).”
BackgroundBourquin, J.-P., Subramanian, A., Langebrake, C., Reinhardt, D., Bernard, O., Ballerini, P., Baruchel, A., Cavé, H., Dastugue, N., Hasle, H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511150103 · Cited by 189
Rieger, M. A., & Schroeder, T. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008250 · Cited by 187
“…fetal HSC generation and self-renewal (e.g., Runx1, Tal1, Notch1 and -2, RBP-J, b-catenin, and HoxB4) only have minimal consequences upon deletion in adult HSCs, whereas overexpression often results in enhanced HSC maintenance, self-renewal, and leukemia (Mikkola et al. 2003; Ichikawa et al. 2004).”
BackgroundMaier, H., Ostraat, R., Gao, H., Fields, S., Shinton, S. A., Medina, K. L., Ikawa, T., Murre, C., Singh, H., Hardy, R. R., et al. (2004) · Nature Immunology · doi:10.1038/ni1119 · Cited by 182
Thomas, T., Corcoran, L. M., Gugasyan, R., Dixon, M. P., Brodnicki, T., Nutt, S. L., Metcalf, D., & Voss, A. K. (2006) · Genes & Development · doi:10.1101/gad.1382606 · Cited by 181
“AML1 is required for the establishment of definitive hematopoiesis (Okuda et al. 1996; Wang et al. 1996), and has a role in both megakaryocyte and T-cell differentiation (Ichikawa et al. 2004).”
InfluentialFunctions of Notch Signaling in the Immune System: Consensus and Controversies
Yuan, J. S., Kousis, P. C., Suliman, S., Visan, I., & Guidos, C. J. (2010) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132719 · Cited by 182
Dysregulated haematopoietic stem cell behaviour in myeloid leukaemogenesis
Yamashita, M., Dellorusso, P. V., Olson, O. C., & Passegué, E. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0260-3 · Cited by 179
Cross-talk between PRMT1-mediated methylation and ubiquitylation on RBM15 controls RNA splicing
Zhang, L., Tran, N.-T., Su, H., Wang, R., Lu, Y., Tang, H., Aoyagi, S., Guo, A., Khodadadi-Jamayran, A., Zhou, D., et al. (2015) · eLife · doi:10.7554/elife.07938 · Cited by 176
Hematopoiesis in the yolk sac: more than meets the eye
McGrath, K. E., & Palis, J. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2005.06.012 · Cited by 176
Zelent, A., Greaves, M., & Enver, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207672 · Cited by 174
“Most recently its role in adult haematopoiesis has been addressed using a conditional knockout approach (Ichikawa et al., 2004).”
BackgroundPreudhomme, C., Renneville, A., Bourdon, V., Philippe, N., Roche-Lestienne, C., Boissel, N., Dhedin, N., André, J.-M., Cornillet-Lefebvre, P., Baruchel, A., et al. (2009) · Blood · doi:10.1182/blood-2008-07-168260 · Cited by 173
Lordier, L., Bluteau, D., Jalil, A., Legrand, C., Pan, J., Rameau, P., Jouni, D., Bluteau, O., Mercher, T., Leon, C., et al. (2012) · Nature Communications · doi:10.1038/ncomms1704 · Cited by 170
“Small diploid MKs are present in the bone marrow of runx1 KO mic”
BackgroundRUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis
Lam, K. (2012) · Frontiers in Bioscience · doi:10.2741/3977 · Cited by 167
“The most striking phenotypes of conditional Runx1 knockout mice are a significant expansion of the putative HSC population (LSK cells) and myeloid progenitors, thrombocytopenia, and lymphopenia (70,71).”
BackgroundTranscriptional control of T-cell development
Naito, T., Tanaka, H., Naoe, Y., & Taniuchi, I. (2011) · International Immunology · doi:10.1093/intimm/dxr078 · Cited by 167
AML1 mutations induced MDS and MDS/AML in a mouse BMT model
Watanabe-Okochi, N., Kitaura, J., Ono, R., Harada, H., Harada, Y., Komeno, Y., Nakajima, H., Nosaka, T., Inaba, T., & Kitamura, T. (2008) · Blood · doi:10.1182/blood-2007-01-068346 · Cited by 150
From hematopoietic stem cells to platelets
Chang, Y., Bluteau, D., Debili, N., & Vainchenker, W. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02472.x · Cited by 196
Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia
on behalf of the International CML Foundation Genomics Alliance, Branford, S., Kim, D. D. H., Apperley, J. F., Eide, C. A., Mustjoki, S., Ong, S. T., Nteliopoulos, G., Ernst, T., Chuah, C., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0512-y · Cited by 149
Cbfβ-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia
Kuo, Y., Landrette, S. F., Heilman, S. A., Perrat, P. N., Garrett, L. J., Liu, P. P., Beau, M. M. L., Kogan, S. C., & Castilla, L. H. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.014 · Cited by 159
Chen, L., Wang, W., Cao, L., Li, Z., & Wang, X. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.2308 · Cited by 148
“…2016; published online 26 February, 2016 Keywords: AML, CCAT1, lncRNA, miR-155 shown that the overgrowth of abnormal myeloid blasts and severe blockage in myeloid differentiation are the major hallmarks of AML (Ichikawa et al., 2004; Jeziskova et al., 2015; Sakurai et al., 2014; Su et al., 2015).”
BackgroundMegakaryocyte biology and related disorders
Pang, L., Weiss, M. J., & Poncz, M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26720 · Cited by 181
The tetramer structure of the Nervy homology two domain, NHR2, is critical for AML1/ETO's activity
Liu, Y., Cheney, M. D., Gaudet, J., Chruszcz, M., Lukasik, S. M., Sugiyama, D., Lary, J. W., Cole, J. L., Dauter, Z., Minor, W., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.012 · Cited by 153
“RUNX1 (AML1) is the sequence-specific DNA binding subunit of a core binding factor that is required at multiple stages of hematopoiesis (Growney et al., 2005; Ichikawa et al., 2004; Okuda et al., 1996; Wang et al., 1996).”
Chen, C., Lin, L., Tang, J., Ko, B., Tsay, W., Chou, W., Yao, M., Wu, S., Tseng, M., & Tien, H. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06811.x · Cited by 134
“…subunit of the heterodimeric CBF complex, which is essential for the development of definitive haematopoiesis (Speck & Gilliland, 2002; de Bruijn & Speck, 2004) Homozygous Runx1 knockout mice die in utero because of impaired haematopoiesis (Higuchi et al, 2002; Ichikawa et al, 2004).”
BackgroundBeck, D., Thoms, J. A. I., Perera, D., Schütte, J., Unnikrishnan, A., Knezevic, K., Kinston, S. J., Wilson, N. K., O’Brien, T. A., Göttgens, B., et al. (2013) · Blood · doi:10.1182/blood-2013-03-490425 · Cited by 133
Genetic regulation of the RUNX transcription factor family has antitumor effects
Morita, K., Suzuki, K., Maeda, S., Matsuo, A., Mitsuda, Y., Tokushige, C., Kashiwazaki, G., Taniguchi, J., Maeda, R., Noura, M., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91788 · Cited by 143
“On the other hand, the conditional knockout of Runx1 in adult mice showed marginal changes in platelet counts without hematopoietic stem cell exhaustion (6), implying that RUNX1 is dispensable for adult hematopoiesis.”
BackgroundA regulatory interplay between miR-27a and Runx1 during megakaryopoiesis
Ben-Ami, O., Pencovich, N., Lotem, J., Levanon, D., & Groner, Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811466106 · Cited by 130
Critical roles for c-Myb in hematopoietic progenitor cells
Greig, K. T., Carotta, S., & Nutt, S. L. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2008.05.003 · Cited by 140
Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11
Landrette, S. F., Kuo, Y., Hensen, K., van Doorn-Khosrovani, S. B. V. W., Perrat, P. N., de Ven, W. J. M. V., Delwel, R., & Castilla, L. H. (2004) · Blood · doi:10.1182/blood-2004-09-3630 · Cited by 144
Carramolino, L., Fuentes, J., García‐Andrés, C., Azcoitia, V., Riethmacher, D., & Torres, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.218073 · Cited by 143
The Proto-Oncogene ERG in Megakaryoblastic Leukemias
Rainis, L., Toki, T., Pimanda, J. E., Rosenthal, E., Machol, K., Strehl, S., Göttgens, B., Ito, E., & Izraeli, S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0147 · Cited by 137
“shown that RUNX1 expression in early hematopoietic progenitor regulates their differentiation toward the lymphoid and the megakaryocytic lineages (12).”
Schulze, H., & Shivdasani, R. A. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01426.x · Cited by 168
Xiao, W., Chan, A. C. L., Waarts, M. R., Mishra, T., Liu, Y., Cai, S. F., Yao, J., Gao, Q., Bowman, R. L., Koche, R. P., et al. (2020) · Blood · doi:10.1182/blood.2020007897 · Cited by 125
Hoogenkamp, M., Lichtinger, M., Krysinska, H., Lancrin, C., Clarke, D., Williamson, A., Mazzarella, L., Ingram, R., Jorgensen, H., Fisher, A., et al. (2009) · Blood · doi:10.1182/blood-2008-11-191890 · Cited by 121
The differential activities of Runx1 promoters define milestones during embryonic hematopoiesis
Sroczynska, P., Lancrin, C., Kouskoff, V., & Lacaud, G. (2009) · Blood · doi:10.1182/blood-2009-05-222307 · Cited by 119
Sun, W., & Downing, J. R. (2004) · Blood · doi:10.1182/blood-2003-12-4349 · Cited by 118
AML1 deletion in adult mice causes splenomegaly and lymphomas
Putz, G., Rosner, A., Nuesslein, I., Schmitz, N., & Buchholz, F. (2005) · Oncogene · doi:10.1038/sj.onc.1209136 · Cited by 132
“In contrast to Ichikawa et al. (2004), our study concentrates on the progression of the phenotype at later timepoints after the induction of the AML1 deletion.”
BackgroundResultInfluentialBluteau, D., Glembotsky, A. C., Raimbault, A., Balayn, N., Gilles, L., Rameau, P., Nurden, P., Alessi, M., Debili, N., Vainchenker, W., et al. (2012) · Blood · doi:10.1182/blood-2012-04-422337 · Cited by 131
A role for RUNX1 in hematopoiesis and myeloid leukemia
Ichikawa, M., Yoshimi, A., Nakagawa, M. M., Nishimoto, N., Watanabe‐Okochi, N., & Kurokawa, M. (2013) · International Journal of Hematology · doi:10.1007/s12185-013-1347-3 · Cited by 144
Self-citationHoi, C. S. L., Lee, S. E., Lu, S.-Y., McDermitt, D. J., Osorio, K. M., Piskun, C. M., Peters, R. M., Paus, R., & Tumbar, T. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01308-09 · Cited by 117
“Runx1 is required in mouse embryos for adult hematopoietic stem cell (HSC) emergence (11, 54), while in adult mice it affects specific hematopoietic lineages (21, 25, 46, 56).”
BackgroundGeddis, A. E. (2010) · Seminars in Hematology · doi:10.1053/j.seminhematol.2010.03.001 · Cited by 158
Taoudi, S., Bee, T., Hilton, A., Knezevic, K., Scott, J., Willson, T. A., Collin, C., Thomas, T., Voss, A. K., Kile, B. T., et al. (2011) · Genes & Development · doi:10.1101/gad.2009211 · Cited by 114
“…have demonstrated that, after hematopoietic specification, RUNX1 is no longer required for continued hematopoietic development (Okuda et al. 1996; Wang et al. 1996; Ichikawa et al. 2004; Chen et al. 2009), but Runx1 is expressed by HSCs in the AGM region and the fetal liver (North et al. 2002).”
BackgroundWong, W. F., Kohu, K., Chiba, T., Sato, T., & Satake, M. (2011) · Immunology · doi:10.1111/j.1365-2567.2010.03381.x · Cited by 112
Runx1 modulates developmental, but not injury-driven, hair follicle stem cell activation
Osorio, K. M., Lee, S. E., McDermitt, D. J., Waghmare, S. K., Zhang, Y. V., Woo, H. N., & Tumbar, T. (2008) · Development · doi:10.1242/dev.012799 · Cited by 112
“, 2002), while its disruption in adulthood leads to an apparent increase of the HSC pool, as defined by cell surface markers (Growney et al., 2005; Ichikawa et al., 2004).”
BackgroundTEL-AML1 Corrupts Hematopoietic Stem Cells to Persist in the Bone Marrow and Initiate Leukemia
Schindler, J. W., Buren, D. V., Foudi, A., Krejci, O., Qin, J., Orkin, S. H., & Hock, H. R. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.04.019 · Cited by 113
“Note that the number of highly purified HSCs was significantly reduced after disruption of AML1. myeloid progenitors, and loss of B cells, are also seen after induced disruption of AML1 in adult mice (Growney et al., 2005; Ichikawa et al., 2004).”
BackgroundStem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis
Jacob, B., Osato, M., Yamashita, N., Wang, C. Q., Taniuchi, I., Littman, D. R., Asou, N., & Ito, Y. (2010) · Blood · doi:10.1182/blood-2009-07-232249 · Cited by 108
Fujimoto, T., Anderson, K., Jacobsen, S. E. W., Nishikawa, S.-I., & Nerlov, C. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601675 · Cited by 113
“In the myeloid lineage, Runx1 is not required for terminal differentiation (Ichikawa et al, 2004).”
BackgroundGutiérrez, L., Tsukamoto, S., Suzuki, M., Yamamoto-Mukai, H., Yamamoto, M., Philipsen, S., & Ohneda, K. (2008) · Blood · doi:10.1182/blood-2007-09-115121 · Cited by 109
STAT1 promotes megakaryopoiesis downstream of GATA-1 in mice
Huang, Z., Richmond, T. D., Muntean, A. G., Barber, D. L., Weiss, M. J., & Crispino, J. D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33010 · Cited by 105
“org Volume 117 Number 12 December 2007 3893 which is required for megakaryocyte maturation and cooperates with GATA-1 in megakaryocyte differentiation (28, 29), was upregulated by STAT1.”
BackgroundHeller, P. G., Glembotsky, A. C., Gandhi, M. J., Cummings, C. L., Pirola, C. J., Marta, R. F., Kornblihtt, L. I., Drachman, J. G., & Molinas, F. C. (2005) · Blood · doi:10.1182/blood-2005-01-0050 · Cited by 104
Cell cycle and developmental control of hematopoiesis by Runx1
Friedman, A. D. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21738 · Cited by 117
“…of common lymphoid progenitors, pro-B, pre-B, and mature B cells; they also harbor T-cell developmental abnormalities, thrombocytopenia, increased granulocyte–monocyte progenitors, and expansion of mature granulocytic and monocytic myeloid cells (Ichikawa et al., 2004; Growney et al., 2005).”
BackgroundChallen, G. A., & Goodell, M. A. (2010) · Experimental Hematology · doi:10.1016/j.exphem.2010.02.011 · Cited by 103
“the bone marrow, show mild defects, including a decrease in platelets (due to a maturational defect of the megakaryocytes), a block of lymphocyte development, and an expansion of hematopoietic progenitors, but no significant impairment to HSC function [9–11].”
BackgroundTirnitz‐Parker, J. E. E., Tonkin, J. N., Knight, B., Olynyk, J. K., & Yeoh, G. C. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.06.008 · Cited by 103
Mangan, J. K., & Speck, N. A. (2011) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v16.i1-2.80 · Cited by 102
Jin, H., Li, L., Xu, J., Zhen, F., Zhu, L., Liu, P. P., Zhang, M., Zhang, W., & Wen, Z. (2012) · Blood · doi:10.1182/blood-2011-12-398362 · Cited by 103
Cyclin D–Cdk4 is regulated by GATA-1 and required for megakaryocyte growth and polyploidization
Muntean, A. G., Pang, L., Poncz, M., Dowdy, S. F., Blobel, G. A., & Crispino, J. D. (2007) · Blood · doi:10.1182/blood-2006-11-059378 · Cited by 115
Coordination of erythropoiesis by the transcription factor c-Myb
Vegiopoulos, A., García, P., Emambokus, N., & Frampton, J. (2006) · Blood · doi:10.1182/blood-2005-07-2968 · Cited by 103
Pencovich, N., Jaschek, R., Tanay, A., & Groner, Y. (2011) · Blood · doi:10.1182/blood-2010-07-295113 · Cited by 103
Engineering Hematopoietic Stem Cells: Lessons from Development
Rowe, R. G., Mandelbaum, J., Zon, L. I., & Daley, G. Q. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.05.016 · Cited by 104
Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia
Antony‐Debré, I., Manchev, V. T., Balayn, N., Bluteau, D., Tomowiak, C., Legrand, C., Langlois, T., Bawa, O., Tosca, L., Tachdjian, G., et al. (2014) · Blood · doi:10.1182/blood-2014-06-585513 · Cited by 111
“In adult murine hematopoietic compartments, RUNX1 is dispensable for HSC maintenance, but it negatively regulates myeloid progenitors while promoting lymphopoiesis and megakaryopoiesis.(15,16) Regarding primitive hematopoiesis, an active yolk sac–derived erythropoiesis(14) and a normal number of primitive erythroid pr…”
BackgroundHuman phenotypes associated with GATA-1 mutations
Ciovacco, W. A., Raskind, W. H., & Kacena, M. A. (2008) · Gene · doi:10.1016/j.gene.2008.09.018 · Cited by 109
“Runx-1 knockout mice are thrombocytopenic due to a halt in MK differentiation, and constitutional Runx-1 haploinsufficiency in humans leads to thrombocytopenia and the aforementioned increased rates of myeloid leukemia (Ichikawa et al., 2004, Song et al., 1999).”
Background
Metadata
- Authors
- Ichikawa, M., Asai, T., Saito, T., Yamamoto, G., Seo, S., Yamazaki, I., Yamagata, T., Mitani, K., Chiba, S., Hirai, H., Ogawa, S., & Kurokawa, M.
- Affiliations
- The University of Tokyo (JP)
- Inoue Hospital (JP)
- Joslin Diabetes Center (US)
- Dokkyo University (JP)
- Corresponding author
- Ogawa, Seishi
- ORCID
- Venue
- Nature Medicine
- Published
- 2004-02-15
- Volume
- 10
- Issue
- 3
- Pages
- 299-304
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2101518963
- Cited by
- 596
- References
- 29
- Citations by year
- 2026: 11 · 2025: 5 · 2024: 10 · 2023: 12 · 2022: 16 · 2021: 28 · 2020: 18 · 2019: 22 · 2018: 20 · 2017: 33 · 2016: 26 · 2015: 23 · 2014: 24 · 2013: 29 · 2012: 27
- FWCI
- 30.73
- Type
- journal article
- Language
- en
- Update notices
- erratum (2005-01-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- RUNX1, lymphocyte differentiation, T cell development, B cell development, hematopoietic stem cells, hematopoietic progenitor cells, adult hematopoiesis, myelodysplastic syndrome
- MeSH terms
- Adult, Animals, Bone Marrow Cells, Cell Differentiation, DNA-Binding Proteins, Hematopoiesis, Hematopoietic Stem Cells, Humans, Lymphocytes, Megakaryocytes, Mice, Inbred Strains, Mice, Transgenic, Proto-Oncogene Proteins, Transcription Factors, Gene Targeting, Cell Lineage, Cell Size, Core Binding Factor Alpha 2 Subunit, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.